1,231
Views
11
CrossRef citations to date
0
Altmetric
Articles

Hallucinogen persisting perception disorder: A literature review and three case reports

, MDORCID Icon, , PhD, MDORCID Icon, , PhD, MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marcus A. Doyle, Susan Ling, Leanna M.W. Lui, Paul Fragnelli, Kayla M. Teopiz, Roger Ho, Joshua D. Di Vincenzo, Joshua D. Rosenblat, Emily S. Gillissie, Danica Nogo, Felicia Ceban, Muhammad Youshay Jawad & Roger S. McIntyre. (2022) Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment. Expert Opinion on Drug Safety 21:6, pages 733-743.
Read now

Articles from other publishers (10)

Seetal Dodd, Trevor R. Norman, Harris A. Eyre, Stephen M. Stahl, Arnie Phillips, André F. Carvalho & Michael Berk. (2022) Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. CNS Spectrums, pages 1-11.
Crossref
H. T. McGovern, P. Leptourgos, B. T. Hutchinson & P. R. Corlett. (2022) Do psychedelics change beliefs?. Psychopharmacology 239:6, pages 1809-1821.
Crossref
Hannah Ford, Clare L. Fraser, Emma Solly, Meaghan Clough, Joanne Fielding, Owen White & Anneke Van Der Walt. (2022) Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature. Frontiers in Neurology 13.
Crossref
R.C. Van Court, M.S. Wiseman, K.W. Meyer, D.J. Ballhorn, K.R. Amses, J.C. Slot, B.T.M. Dentinger, R. Garibay-Orijel & J.K. Uehling. (2022) Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development. Fungal Biology 126:4, pages 308-319.
Crossref
Robertas Strumila, Bénédicte Nobile, Laura Korsakova, Aiste Lengvenyte, Emilie Olie, Jorge Lopez-Castroman, Sébastien Guillaume & Philippe Courtet. (2021) Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. Pharmaceuticals 14:12, pages 1213.
Crossref
Kristin Waters. (2021) Pharmacologic Similarities and Differences Among Hallucinogens. The Journal of Clinical Pharmacology 61:S2.
Crossref
Giovanni Martinotti, Luisa De Risio, Chiara Vannini, Fabrizio Schifano, Mauro Pettorruso & Massimo Di Giannantonio. (2020) Substance-related exogenous psychosis: a postmodern syndrome. CNS Spectrums 26:1, pages 84-91.
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Katherine A. Coerver & Prem S. Subramanian. (2020) Visual hallucinations in psychiatric, neurologic, and ophthalmologic disease. Current Opinion in Ophthalmology 31:6, pages 475-482.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.